International study on COVID-19 Vaccine to assess Immunogenicity, Reactogenicity and Efficacy (InVITE)

这笔资金支持了一项关于新冠肺炎疫苗免疫原性和持久性以及通过本国国家疫苗接种计划接受新冠肺炎疫苗的人中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的多中心研究。这项研究将在国际网站上进行，包括那些参与临床研究特别项目部的网站。这项研究的独特之处在于，它检查了几个国家的多种不同疫苗接种方案(包括初始接种方案和加强接种方案)的免疫原性。

This funding supports a multicenter study of COVID-19 vaccine immunogenicity and durability, and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections in people who receive a COVID-19 vaccine through their country’s national vaccination programs. The study will be conducted in international sites including those that participate in the Division of Clinical Research Special Projects. This study is unique in that it examines the immunogenicity of multiple different vaccination regimens (both initial and booster) across several countries.